Bardet-Biedl Syndrome 7 (BBS7) Peptide
BBS7
Reactivity: Human, Rat
Host: Synthetic
BP, BI
Catalog No. ABIN5684860
Quick Overview for Bardet-Biedl Syndrome 7 (BBS7) Peptide (ABIN5684860)
Target
BBS7
(Bardet-Biedl Syndrome 7 (BBS7))
Origin
Human, Rat
Source
Synthetic
Application
Blocking Peptide (BP), BioImaging (BI)
-
-
Characteristics
- BBS7 peptide corresponds to 12 amino acids of BBS7.
-
-
-
-
Application Notes
- BBS7 peptide is used for blocking the activity of BBS7 antibody . The BBS7 antibody ships at 0.5 mg/mL and the STK36 Peptide ships as a 100 μg pellet. When peptide is reconstituted in 200 μLwater, the concentration will be 0.5 mg/mL, identical to that of the antibody. The best starting ratio would be 1:1 (which means molar excess of peptide relative to antibody when identical volumes are mixed). Mix equal volume of peptide and antibody at the required dilution and leave at ambient temperature for 20 minutes. Then incubate and develop in parallel two blots: one with the antibody and one with the antibody which has been pre-absorbed with the provided peptide..
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- BBS7 peptide is supplied as 100 µg of dried peptide. When the peptide is reconstituted in 200 µL water, the concentration will be 0.5 mg/mL.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20°C. When reconstituted minimize freezing and thawing.
-
-
-
You are here:
